Nevertheless, during retinoblastoma progression, upregulation of MDM2/4 prevents p53-mediated apoptosis, thus promoting tumor survival and favoring uncontrolled cell proliferation by reducing basal levels of p53 (10, 12). This evidence concerns the gene TP53 and retinoblastoma.